Bjorkholm M, Fagrell B, Przybelski R, Winslow N, Young M, Winslow R. A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. Haematologica [Internet]. 2005Apr.1 [cited 2026Nov.7];90(4):505-1. Available from: https://haematologica.org/article/view/3482